Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, PR China.
Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, PR China; Department of Experimental Research, Sun Yat-sen University Cancer Center, Guangzhou 510060, PR China; Department of Medical Oncology, National Cancer Centre of Singapore, Singapore 169610, Singapore.
J Genet Genomics. 2021 Jul 20;48(7):595-605. doi: 10.1016/j.jgg.2021.05.006. Epub 2021 Jun 15.
RNA binding motif proteins (RBMs) have been widely implicated in the tumorigenesis of multiple human cancers but scarcely studied in nasopharyngeal carcinoma (NPC). Here, we compare the mRNA levels of 29 RBMs between 87 NPC and 10 control samples. We find that RBM47 is frequently upregulated in NPC specimens, and its high expression is associated with the poor prognosis of patients with NPC. Biological experiments show that RBM47 plays an oncogenic role in NPC cells. Mechanically, RBM47 binds to the promoter and regulates the transcription of BCAT1, and its overexpression partially rescues the inhibitory effects of RBM47-knockdown on NPC cells. Moreover, transcriptome analysis reveals that RBM47 regulates alternative splicing of pre-mRNA, including those cancer-related, to a large extent in NPC cells. Furthermore, RBM47 binds to hnRNPM and cooperatively regulates multiple splicing events in NPC cells. In addition, we find that knockdown of hnRNPM inhibits proliferation and migration of NPC cells. Our study, taken together, shows that RBM47 promotes the progression of NPC through multiple pathways, acting as a transcriptional factor and a modulator of alternative splicing in cooperation with hnRNPM. Our study also highlights that RBM47 and hnRNPM could be prognostic factors and potential therapeutic targets for NPC.
RNA 结合基序蛋白(RBMs)广泛参与多种人类癌症的肿瘤发生,但在鼻咽癌(NPC)中研究甚少。在这里,我们比较了 87 个 NPC 和 10 个对照样本中 29 个 RBM 的 mRNA 水平。我们发现 RBM47 在 NPC 标本中经常上调,其高表达与 NPC 患者的预后不良相关。生物学实验表明,RBM47 在 NPC 细胞中发挥致癌作用。在机制上,RBM47 结合到启动子并调节 BCAT1 的转录,其过表达部分挽救了 RBM47 敲低对 NPC 细胞的抑制作用。此外,转录组分析表明,RBM47 很大程度上调节 NPC 细胞中前体 mRNA 的可变剪接,包括那些与癌症相关的。此外,RBM47 与 hnRNPM 结合,并在 NPC 细胞中协同调节多个剪接事件。此外,我们发现 hnRNPM 的敲低抑制 NPC 细胞的增殖和迁移。我们的研究表明,RBM47 通过多种途径促进 NPC 的进展,作为转录因子和与 hnRNPM 合作的可变剪接调节剂。我们的研究还强调,RBM47 和 hnRNPM 可能是 NPC 的预后因素和潜在的治疗靶点。